Mechanisms and treatment of late-life depression

GS Alexopoulos - Translational psychiatry, 2019 - nature.com
Depression predisposes to medical illnesses and advances biological aging indicated by
shorter telomere length, accelerated brain aging and advanced epigenetic aging. Medical …

Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and–specific lesion patterns

Y Chen, M Dang, Z Zhang - Molecular Neurodegeneration, 2021 - Springer
Neuropsychiatric symptoms (NPSs) are common in patients with Alzheimer's disease (AD)
and are associated with accelerated cognitive impairment and earlier deaths. This review …

Mood disorders in the elderly: prevalence, functional impact, and management challenges

LCL Valiengo, F Stella, OV Forlenza - … disease and treatment, 2016 - Taylor & Francis
Despite the lower prevalence of severe mood disorders in the elderly as compared to
younger adults, late-life depression and bipolar disorder (BD) are more strongly associated …

Beyond haemostasis and thrombosis: platelets in depression and its co-morbidities

B Izzi, A Tirozzi, C Cerletti, MB Donati… - International Journal of …, 2020 - mdpi.com
Alongside their function in primary haemostasis and thrombo-inflammation, platelets are
increasingly considered a bridge between mental, immunological and coagulation-related …

Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic

Y Zhao, X Wu, M Tang, L Shi, S Gong, X Mei… - Frontiers in …, 2023 - frontiersin.org
Late-life depression (LLD) is one of the most common mental disorders among the older
adults. Population aging, social stress, and the COVID-19 pandemic have significantly …

Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth …

SA Torrisi, F Geraci, MR Tropea, M Grasso… - Frontiers in …, 2019 - frontiersin.org
Depression is a risk factor for the development of Alzheimer's disease (AD), and the
presence of depressive symptoms significantly increases the conversion of mild cognitive …

Selective serotonin reuptake inhibitors and Alzheimer's disease

B Mdawar, E Ghossoub, R Khoury - Neural regeneration research, 2020 - journals.lww.com
Given the failure to develop disease-modifying therapies for Alzheimer's disease (AD),
strategies aiming at preventing or delaying the onset of the disease are being prioritized …

Late-life depression is associated with reduced cortical amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Depression Project

RS Mackin, PS Insel, S Landau, D Bickford, R Morin… - Biological …, 2021 - Elsevier
Background We evaluated the role of cortical amyloid deposition as a factor contributing to
memory dysfunction and increased risk of dementia associated with late-life depression …

Neuropsychiatric disturbances in mild cognitive impairment: a scientometric analysis

A Amrapala, M Sabe, M Solmi, M Maes - Ageing Research Reviews, 2023 - Elsevier
Behavioral and psychological symptoms of dementia (BPSD) have been extensively studied
in dementia than its prodromal stage, known as mild cognitive impairment (MCI). A …

Amyloid hypothesis: is there a role for antiamyloid treatment in late-life depression?

N Mahgoub, GS Alexopoulos - The American Journal of Geriatric …, 2016 - Elsevier
Antidepressants have modest efficacy in late-life depression (LLD), perhaps because
various neurobiologic processes compromise frontolimbic networks required for …